Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Linear Formula:
CH3COONa
CAS Number:
Molecular Weight:
82.03
NACRES:
NA.21
PubChem Substance ID:
eCl@ss:
39021906
UNSPSC Code:
12352300
EC Number:
204-823-8
MDL number:
Beilstein/REAXYS Number:
3595639
InChI key
VMHLLURERBWHNL-UHFFFAOYSA-M
InChI
1S/C2H4O2.Na/c1-2(3)4;/h1H3,(H,3,4);/q;+1/p-1
SMILES string
[Na+].CC([O-])=O
grade
anhydrous
agency
USP/NF, meets USP testing specifications
assay
99-101% dry basis
form
solid
autoignition temp.
1112 °F
pH
8.5-9.9 (25 °C, 246 g/L)
Quality Level
mp
>300 °C (dec.) (lit.)
solubility
soluble 246 g/L at 20 °C (completely)
application(s)
pharmaceutical (small molecule)
Looking for similar products? Visit Product Comparison Guide
Related Categories
General description
Sodium acetate (SA) exhibits antimicrobial and antioxidant properties. It is used as an exchange-fluid buffer in hemodialysis. SA acts as an a alkalinizing agent and its continuous intravenous (IV) infusion causes salicylate intoxication.
Application
Sodium acetate (SA) has been used to increase hepatic acetyl- coenzyme A in caloric restricted rats.
Storage Class
11 - Combustible Solids
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Sodium Acetate as an Alkalinizing Agent for Salicylate Intoxication: A Case Report
Groke SF, et al.
Journal of Clinical Toxicology (2015)
Enhancement of in-vitro human interleukin-1 production by sodium acetate
Bingel M, et al.
Lancet, 329(8523), 14-16 (1987)
Antimicrobial and antioxidant effects of sodium acetate, sodium lactate, and sodium citrate in refrigerated sliced salmon
Sallam KI, et al.
Food Control, 18(5), 566-575 (2007)
Mechanisms by which a very-low-calorie diet reverses hyperglycemia in a rat model of type 2 diabetes
Perry RJ, et al.
Cell Metabolism, 27(1), 210-217 (2018)
Carol L Ladner-Keay et al.
PloS one, 9(6), e98753-e98753 (2014-06-04)
The formation of β-sheet rich prion oligomers and fibrils from native prion protein (PrP) is thought to be a key step in the development of prion diseases. Many methods are available to convert recombinant prion protein into β-sheet rich fibrils
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service